Keywords: Mylan, Actoplus, Diabetes, Takeda, Watson, Andrx

Mylan confirms Actoplus patent challenge

Article | 09 January 2012

US generic drugmaker Mylan (Nasdaq: MYL) has confirmed that it has been sued by Takeda Pharmaceutical (TYO: 4502), Watson Pharmaceuticals (NYSE: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Watson Pharmaceuticals

Andrx

Mylan Laboratories

Takeda Pharmaceuticals

Go to company listing